78 related articles for article (PubMed ID: 12914943)
1. Mosaic particles formed by wild-type hepatitis B virus core protein and its deletion variants consist of both homo- and heterodimers.
Kazaks A; Dishlers A; Pumpens P; Ulrich R; Krüger DH; Meisel H
FEBS Lett; 2003 Aug; 549(1-3):157-62. PubMed ID: 12914943
[TBL] [Abstract][Full Text] [Related]
2. Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles.
Preikschat P; Kazaks A; Dishlers A; Pumpens P; Krüger DH; Meisel H
FEBS Lett; 2000 Jul; 478(1-2):127-32. PubMed ID: 10922483
[TBL] [Abstract][Full Text] [Related]
3. Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface.
Kazaks A; Borisova G; Cvetkova S; Kovalevska L; Ose V; Sominskaya I; Pumpens P; Skrastina D; Dislers A
J Gen Virol; 2004 Sep; 85(Pt 9):2665-2670. PubMed ID: 15302960
[TBL] [Abstract][Full Text] [Related]
4. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
[TBL] [Abstract][Full Text] [Related]
5. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
[TBL] [Abstract][Full Text] [Related]
6. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
[TBL] [Abstract][Full Text] [Related]
7. Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells.
Preikschat P; Borisova G; Borschukova O; Dislers A; Mezule G; Grens E; Kr ºger DH; Pumpens P; Meisel H
J Gen Virol; 1999 Jul; 80 ( Pt 7)():1777-1788. PubMed ID: 10423147
[TBL] [Abstract][Full Text] [Related]
8. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein.
Chu TH; Liou AT; Su PY; Wu HN; Shih C
J Virol; 2014 Mar; 88(5):2530-43. PubMed ID: 24352445
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B core particles as a universal display model: a structure-function basis for development.
Pumpens P; Grens E
FEBS Lett; 1999 Jan; 442(1):1-6. PubMed ID: 9923592
[TBL] [Abstract][Full Text] [Related]
12. Folding and assembly of hepatitis B virus core protein: a new model proposal.
Bringas R
J Struct Biol; 1997 Apr; 118(3):189-96. PubMed ID: 9169229
[TBL] [Abstract][Full Text] [Related]
13. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.
Weigand K; Knaust A; Schaller H
J Gen Virol; 2010 Jan; 91(Pt 1):59-67. PubMed ID: 19741067
[TBL] [Abstract][Full Text] [Related]
14. Proline-138 is essential for the assembly of hepatitis B virus core protein.
Metzger K; Bringas R
J Gen Virol; 1998 Mar; 79 ( Pt 3)():587-90. PubMed ID: 9519838
[TBL] [Abstract][Full Text] [Related]
15. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
Parekh S; Zoulim F; Ahn SH; Tsai A; Li J; Kawai S; Khan N; Trépo C; Wands J; Tong S
J Virol; 2003 Jun; 77(12):6601-12. PubMed ID: 12767980
[TBL] [Abstract][Full Text] [Related]
16. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
[TBL] [Abstract][Full Text] [Related]
17. HBV core particles as a carrier for B cell/T cell epitopes.
Pumpens P; Grens E
Intervirology; 2001; 44(2-3):98-114. PubMed ID: 11509871
[TBL] [Abstract][Full Text] [Related]
18. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
Mohamed Suffian IFB; Wang JT; Hodgins NO; Klippstein R; Garcia-Maya M; Brown P; Nishimura Y; Heidari H; Bals S; Sosabowski JK; Ogino C; Kondo A; Al-Jamal KT
Biomaterials; 2017 Mar; 120():126-138. PubMed ID: 28056402
[TBL] [Abstract][Full Text] [Related]
19. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
20. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
